Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
1.
Angew Chem Int Ed Engl ; : e202406054, 2024 Jul 09.
Article de Anglais | MEDLINE | ID: mdl-38980317

RÉSUMÉ

Electrochemical impedance spectroscopy (EIS), characterized by its non-destructive and in-situ nature, plays a crucial role in comprehending the thermodynamic and kinetic processes occurring with Li-ion batteries. However, there is a lack of consistent and coherent physical interpretations for the EIS of porous electrodes. Therefore, it is imperative to conduct thorough investigations into the underlying physical mechanisms of EIS. Herein, by employing reference electrode in batteries, we revisit the associated physical interpretation of EIS at different frequency. Combining different battery configurations, temperature-dependent experiments, and elaborated distribution of relaxation time analysis, we find that the ion transport in porous electrode channels and pseudo-capacitance behavior dominate the high-frequency and mid-frequency impedance arcs, respectively. This work offers a perspective for the physical interpretation of EIS and also sheds light on the understanding of EIS characteristics in other advanced energy storage systems.

2.
Zhonghua Yi Xue Za Zhi ; 89(7): 472-5, 2009 Feb 24.
Article de Chinois | MEDLINE | ID: mdl-19567097

RÉSUMÉ

OBJECTIVE: To investigate the relationship between neuroendocrine differentiation (NED) in prostate cancer and hormone refractory prostate cancer. METHODS: Fifty-five prostate cancer specimens were obtained from 55 patients following intermittent androgen blockade during operation of transurethral resection of prostate. Monoclonal antibody immunohistochemistry was used to detect the expression of chromogranin A (CgA), a specific marker of neuroendocrine cell in the specimens. Follow-up was conducted for 25 (5 - 85) months. Serum prostate specific antigen (PSA), bone scan, chest X-ray, and computerized tomography were performed regularly during follow-up. RESULTS: Twenty-six of the 55 specimens (47.3%) were positive in CaG, and 23 of the 35 tumors with the Gleason score >or= 7 was 66%, significantly higher than those of the lower-grade tumors (all P < 0.01). Most of the high-grade tumors showed small cluster pattern, and most of the low-grade tumors showed solitary scattered pattern. The numbers of NED cells in the stage III and IV tumors were 67% and 71.4% respectively, both significantly higher than that of the stage II tumors (25%, both P < 0.05), There was no correlation between the NE positive cell rate and preoperative PSA value (P > 0.05). Thirty cases progressed to a hormone-independent status within 18 (5 - 79) months (Group A), and the rest 25 cases remained not progressing within 31 (17 - 85) months (Group B). The NED rate of Group A was significantly higher than that of Group B (P < 0.05). Univariate analysis showed that NE positivity, Gleason >or= 7, stage IV, and bone metastasis were influential factors of clinical progression. Multivariate COX regression analysis showed that NED and pre-operational PSA value were independent prognostic factors of bone metastasis. CONCLUSION: NED is associated with poor prognosis and hormone refractory prostate cancer in patients with androgen deprivation therapy.


Sujet(s)
Tumeurs neuroendocrines/anatomopathologie , Tumeurs de la prostate/anatomopathologie , Sujet âgé , Antagonistes des androgènes/usage thérapeutique , Chromogranine A/sang , Études de suivi , Humains , Mâle , Cellules neuroendocrines/cytologie , Tumeurs neuroendocrines/traitement médicamenteux , Tumeurs neuroendocrines/métabolisme , Pronostic , Tumeurs de la prostate/traitement médicamenteux , Tumeurs de la prostate/métabolisme
3.
Ai Zheng ; 28(2): 150-3, 2009 Feb.
Article de Anglais | MEDLINE | ID: mdl-19550127

RÉSUMÉ

BACKGROUND AND OBJECTIVE: Androgen blockade is the principle strategy in the treatment of advanced prostate cancer. Impaired glucose tolerance often occurs in those patients after androgen blockade. This study was to investigate the correlation of insulin resistance to intermittent androgen blockade (IAB) or continuous androgen blockade, which is also named surgical castration, in patients with advanced prostate cancer. METHODS: A total of 139 patients with advanced prostate cancer were classified into four groups according to the body mass index (BMI) and the treatment method. Group A consisted of 30 patients receiving surgical castration with BMI >or= 24 kg/m(2), group B consisted of 32 patients treated with IAB with BMI >or= kg/m(2), group C consisted of 37 patients undergoing surgical castration with BMI < 24 kg/m(2), group D consisted of 40 patients treated by IAB with BMI < 24 kg/m(2). Fasting plasma glucose (FPG) and fasting serum level of insulin (FINS) were assessed before treatment, six months and 12 months after treatment, respectively. Insulin resistance index (IRI) was also calculated. RESULTS: Six months after treatment, FINS and IRI were all increased in the four groups compared with those before treatment; FINS and IRI were significantly higher in groups B and D than in A and C (FINS: t(A:B)=7.7516, p < 0.01, t(C:D)=4.8078, p < 0.01; IRI: t(A:B) =7.3671, p < 0.01, t(C:D)=5.1005, p < 0.01). Twelve months after treatment, which was the intermittent period of the IAB method, FINS returned to the pretreatment level in group D (q=2.5255, p > 0.05), and dramatically decreased in group B compared to the value six months after treatment (q = 9.0942, p < 0.01); in contrast, FINS and IRI remained unchanged in groups A and C. CONCLUSIONS: Androgen blockade promotes insulin resistance in patients with advanced prostate cancer. Insulin resistance gradually disappears during the intermittent period of IAB.


Sujet(s)
Antagonistes des androgènes/usage thérapeutique , Insulinorésistance , Orchidectomie , Tumeurs de la prostate/sang , Glycémie/analyse , Indice de masse corporelle , Jeûne/sang , Humains , Insuline/sang , Mâle , Monitorage physiologique/méthodes , Tumeurs de la prostate/anatomopathologie , Tumeurs de la prostate/thérapie , Facteurs temps , Résultat thérapeutique
4.
Zhonghua Yi Xue Za Zhi ; 86(1): 39-41, 2006 Jan 03.
Article de Chinois | MEDLINE | ID: mdl-16606534

RÉSUMÉ

OBJECTIVE: To investigate the etiology, diagnosis, and management of spontaneous perirenal hemorrhage (SPH). METHODS: The clinical data of 35 patients, 10 males and 12 females, aged 35.9 (12-77), with the diagnosis of SPH, without history of trauma, anticoagulant use, dialysis, and renal transplantation, were analyzed. RESULTS: The underlying disease of SPH included angiomyolipoma (18 cases), renal cell carcinoma (7 cases), kidney cyst (2 cases), renal artery aneurysm (3 cases), rupture of renal artery aneurysm accompanied with pregnancy (2 cases), renal pheochromocytoma (3 cases 2 of which accompanied with pregnancy), congenital stricture of pelvic ureter junction (1 case), and liver cancer (1 case). The most common underlying diseases were nephrogenic (96%) with angiomyolipoma ranking first (54%) followed by renal cell carcinoma (21%). The underlying diseases were diagnosed correctly in 23 cases (69%). CT helped in diagnosis of 34 cases. Surgery was performed on most of the cases. CONCLUSION: The most common causes of SPH is renal neoplasms more than 50% of which are benign. Renal artery aneurysm and pheochromocytoma tend to rupture during pregnancy. CT is the first method of choice in diagnosis.


Sujet(s)
Hémorragie/imagerie diagnostique , Hémorragie/thérapie , Maladies du rein/imagerie diagnostique , Maladies du rein/thérapie , Adolescent , Adulte , Sujet âgé , Anévrysme/complications , Angiographie de soustraction digitale , Angiomyolipome/complications , Anticoagulants/usage thérapeutique , Enfant , Femelle , Hémorragie/étiologie , Humains , Maladies du rein/étiologie , Tumeurs du rein/complications , Transplantation rénale , Mâle , Adulte d'âge moyen , Grossesse , Artère rénale/anatomopathologie , Dialyse rénale , Tomodensitométrie , Résultat thérapeutique
5.
Ai Zheng ; 22(4): 421-3, 2003 Apr.
Article de Chinois | MEDLINE | ID: mdl-12704004

RÉSUMÉ

BACKGROUND & OBJECTIVE: Superficial bladder transitional cell carcinoma is aggressive and tends to recurrence after operation. In order to prevent the relapse of bladder neoplasms,this study was designed to explore the effect of intravesical instillation of pirarubicin (THP) together with polyvinylpyrrolidone (PVP) on patients with superficial bladder cancer who had undergone surgical operation. METHODS: A total of 34 cases were enrolled from October 1999 to May 2002. After one week of operation, pirarubicin (20 mg) dissolved in 10 ml normal saline plus 20 ml PVP was instilled into bladder, and was retained for 60 minutes. In the following 7 weeks, intravesical instillation of pirarubicin was administered once a week. Subsequently it was done bi-monthly, finally once a month for 6 months. RESULTS: Follow-up was performed for 5-26 months (mean:17.2 months). Among the 34 cases, recurrence was found in 2 cases (5.8%),bladder irritation in 6 cases (17.6%) and hematuria in 4 cases (11.7%) as well. CONCLUSION: Intravesical instillation of THP/PVP is effective for prevention of postoperative recurrence of superficial bladder cancer with fewer side effects. Further study is needed for wide use in such way.


Sujet(s)
Antibiotiques antinéoplasiques/usage thérapeutique , Doxorubicine/analogues et dérivés , Doxorubicine/usage thérapeutique , Povidone/usage thérapeutique , Tumeurs de la vessie urinaire/traitement médicamenteux , Administration par voie vésicale , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Association de médicaments , Femelle , Humains , Mâle , Adulte d'âge moyen , Excipients pharmaceutiques/usage thérapeutique , Période postopératoire , Récidive
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE